These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30208436)

  • 1. HIV Preexposure Prophylaxis "Smart Pill" in Early Testing.
    Abbasi J
    JAMA; 2018 Sep; 320(10):965. PubMed ID: 30208436
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral Preexposure Prophylaxis: Opportunities and Challenges for Primary Care Physicians.
    Mayer KH; Krakower DS; Boswell SL
    JAMA; 2016 Mar; 315(9):867-8. PubMed ID: 26893026
    [No Abstract]   [Full Text] [Related]  

  • 3. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological methods to measure adherence to antiretroviral therapy and preexposure prophylaxis.
    Garrison LE; Haberer JE
    Curr Opin HIV AIDS; 2017 Sep; 12(5):467-474. PubMed ID: 28590335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of medication therapy management in preexposure prophylaxis therapy for HIV prevention.
    Ferrell KW; Woodard LM; Woodard TJ
    J Pharm Pract; 2015 Feb; 28(1):10-2. PubMed ID: 25500557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    Sheth AN; Momplaisir F; Dumond JB
    JAMA; 2024 Mar; 331(11):912-914. PubMed ID: 38427361
    [No Abstract]   [Full Text] [Related]  

  • 7. High Adherence to HIV Pre-Exposure Prophylaxis among Veterans.
    Huang M; Liu W; Plomondon ME; Prochazka AV; Bessesen MT
    J Gen Intern Med; 2018 Mar; 33(3):253-255. PubMed ID: 29302884
    [No Abstract]   [Full Text] [Related]  

  • 8. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preexposure Prophylaxis Is for Women, Too.
    Blackstock OJ
    Mayo Clin Proc; 2018 Mar; 93(3):395-396. PubMed ID: 29502571
    [No Abstract]   [Full Text] [Related]  

  • 10. Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies.
    Koenig LJ; Lyles C; Smith DK
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S91-8. PubMed ID: 23253769
    [No Abstract]   [Full Text] [Related]  

  • 11. Educating the Primary Care Clinician on Preexposure Prophylaxis for Human Immunodeficiency Virus: A Teachable Moment.
    Lu PM; Shearer LS; Edelman EJ
    JAMA Intern Med; 2016 Jul; 176(7):890-1. PubMed ID: 27270360
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention.
    Murnane PM; Brown ER; Donnell D; Coley RY; Mugo N; Mujugira A; Celum C; Baeten JM;
    Am J Epidemiol; 2015 Nov; 182(10):848-56. PubMed ID: 26487343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; Curlin ME; Na-Pompet S; Warapronmongkholkul A; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Choopanya K;
    AIDS; 2015 Apr; 29(7):819-24. PubMed ID: 25985403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PURLs: On-demand pill protocol protects against HIV.
    Justesen K; Prasad S
    J Fam Pract; 2016 Aug; 65(8):556-8. PubMed ID: 27660840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
    Ebell MH
    Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839
    [No Abstract]   [Full Text] [Related]  

  • 16. Daily Pill Can Prevent HIV. Reaching people who could benefit from PrEP.
    J Miss State Med Assoc; 2015 Dec; 56(12):387-90. PubMed ID: 26975166
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm.
    Haberer JE; Bangsberg DR; Baeten JM; Curran K; Koechlin F; Amico KR; Anderson P; Mugo N; Venter F; Goicochea P; Caceres C; O'Reilly K
    AIDS; 2015 Jul; 29(11):1277-85. PubMed ID: 26103095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical issues in trials of preexposure prophylaxis.
    Dunn DT; Glidden DV
    Curr Opin HIV AIDS; 2016 Jan; 11(1):116-21. PubMed ID: 26545264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrEP works.
    Jefferys R
    IAVI Rep; 2015; 19(1):4-10, 19. PubMed ID: 26043498
    [No Abstract]   [Full Text] [Related]  

  • 20. US Guidelines That Empower Women to Prevent HIV With Preexposure Prophylaxis.
    Raifman J; Sherman SG
    Sex Transm Dis; 2018 Jun; 45(6):e38-e39. PubMed ID: 29750776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.